THE KIDS AREN’T ALRIGHT — The CDC will host a Clinician Outreach and Communication Activity call today for practitioners around the country to learn more about diagnosing and treating children with long Covid. Though it’s unclear how many kids suffer from the condition, multidisciplinary clinics nationwide that treat long Covid in children still have long waiting lists. Krista spoke with Amanda Morrow, co-director of the pediatric post-Covid-19 clinic at Kennedy Krieger Institute, about long Covid in kids. She will present new guidance on the call to help primary care physicians recognize and provide early treatment for the condition. The interview has been edited for length and clarity. What is happening with kids and long Covid right now? What are you seeing in your practice? Unfortunately, this doesn’t seem to be going away. There is a group of children who will develop prolonged symptoms after Covid infection. We’ve even seen some children who have developed long COVID after their second or third bout of acute Covid. We’ve learned a lot, but there's still so much more that we need to discover about long Covid, about how it affects kids, and about the best treatment option. Is it still hard for kids to get care for long Covid? Yes. Our pediatricians are doing a great job trying to start helping these kids, and some of them are improving before they end up having to come to a clinic like ours, which is so specialized. But there’s still a lack of resources for some children who have a variety of symptoms across multiple organ systems. … Some of these kids need a multidisciplinary approach with different providers — therapists, psychologists, social worker support, counselors — to look at patients in a holistic way. Why does this worry you in the long term? I really worry about children’s loss of quality of life and normalcy — being able to hang out with their friends, being able to go to school, being able to participate in their extracurricular activities. I want them to be able to succeed and be able to get back to where they were before they got sick. Do you think the federal government is doing what it should be doing? I do think that there have been initiatives, and the federal government is providing additional support for research into this condition. Could there be more? Sure. … I think we all wish that more could be done as soon as possible. WELCOME TO THURSDAY PULSE, where we recently learned that cocaine bear (soon to be the star of a feature film) isn’t the only animal to get into human substances. From marijuana to McFlurries, animals seem to be partaking in whatever they can, according to an enlightening report from the Times. Any animal sightings to report? What about health news or tips? Drop us a line at dpayne@politico.com and kmahr@politico.com. TODAY ON OUR PULSE CHECK PODCAST, host Ruth Reader talks with Megan R. Wilson about the growing calls to enact reforms to pharmaceutical middlemen after years of largely unsuccessful attempts by lawmakers, while reform advocates hope conditions are ripe this year for action. Megan also expounds on the bills introduced so far and how PBMs are fighting back.
|